Psychological Therapies: The Missing Link in Improving Treatment Adherence in Patients with β-thalassemia Major

Authors

  • Abbas Heydari Evidence- Based Care Research Center, Mashhad University of Medical Sciences, Mashhad, Iran, and Department of Medical-Surgical Nursing, School of Nursing and Midwifery, Mashhad University of Medical Sciences, Mashhad, Iran
  • Amir Emami Zeydi Student Research Committee, PhD candidate in Nursing, Department of Medical-Surgical Nursing, School of Nursing and Midwifery, Mashhad University of Medical Sciences, Mashhad, Iran
  • Hossein Karimi Moonaghi Evidence- Based Care Research Center, Mashhad University of Medical Sciences, Mashhad, Iran, and Department of Medical-Surgical Nursing, School of Nursing and Midwifery, Mashhad University of Medical Sciences, Mashhad, Iran
Abstract:

This article doesn't have abstract

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Regular Reminding of the Potential Serious Complications of Poor Adherence to Treatment: A Strategy for Improving Treatment Adherence in Beta-Thalassemia Major Patients

Globally, β-Thalassemia Major (β-TM) is the most commonly inherited hemolytic anemia, with a high incidence rate in Southeast Asia, the Middle East and Mediterranean countries. Patients with β-TM require lifelong adherence to their distressing treatment regimens, including regular blood transfusions and daily chelation therapy.

full text

Depression and the affecting factors in patients with β Thalassemia Major having referred to Saravan city thalassemia center in 2017

Abstract Background and Objectives The chronic nature of thalassemia affects different aspects of patients' life and increases depression.The goal of the study was to determine depression and the affecting factors in patients with thalassemia major reffered to Saravan thalassemia center.   Materials and Methods The population of this descriptive analytic study consisted of 60 thalassemic pat...

full text

Analysis of Survival in Patients with β-thalassemia Major in Guilan, Northern Iran

Background: Advances in treatment of thalassemia major (TM) have improved life expectancy and survival of the patients. This study was conducted to assess survival rate of these patients in Guilan province, Northern Iran. Methods: In this cross-sectional study, records of 1243 patients with TM from 2001 to March 2016 were evaluated in Guilan province. Sources of data were health centers of the...

full text

Therapeutic approaches in patients with β-thalassemia

Beta-thalassemia (β-thal) is a congenital hemoglobinopathy explained by a decreased level (β+) or absence (βο) of β-globin gene expression. Microcytic hypochromic anemia and various clinical symptoms comprising severe anemia to clinically nonsymptomatic features. Treatment with an ordered blood transfusion and iron chelator agents can decrease transfusion iron overload that causes normal matura...

full text

Dental Treatment Needs in Thalassemia Major Patients, Sari, Iran

Background and purpose: Patients with thalassemia major need more dental care because of their special health conditions. The purpose of this study was to evaluate dental health and therapeutic needs of these patients in Sari, Iran 2018. Materials and methods: A descriptive cross-sectional study was done using a researcher-made form and direct observation in 144 cases attending Sari Thalassemi...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 9  issue None

pages  130- 131

publication date 2017-12

By following a journal you will be notified via email when a new issue of this journal is published.

Keywords

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023